Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is vascular mortality increased in hypopituitarism?

E M Erfurth1, B Bülow, L E Hagmar

  • 1Department of Internal Medicine, Division of Endocrinology, University Hospital, SE-221 85 Lund, Sweden. Eva-Marie.Erfurth@med.lu.se

Pituitary
|January 6, 2001
PubMed
Summary

Patients with hypopituitarism face a higher risk of vascular mortality. Existing studies suggest a 50% increased risk, but methodological flaws likely mean the true risk is even greater.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity.

International journal of obesity (2005)·2018
Same author

Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma.

European journal of endocrinology·2018
Same author

GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.

European journal of endocrinology·2015
Same author

Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality.

The Journal of clinical endocrinology and metabolism·2013
Same author

Moderate dose cranial radiotherapy causes central adrenal insufficiency in long-term survivors of childhood leukaemia.

Pituitary·2013
Same author

Bone loss after childhood acute lymphoblastic leukaemia: an observational study with and without GH therapy.

European journal of endocrinology·2011

Area of Science:

  • Endocrinology
  • Epidemiology
  • Clinical Research

Background:

  • Four cohort studies examined life expectancy in hypopituitarism patients.
  • Acromegaly, Cushing's disease, and GH replacement were excluded.
  • A meta-analysis indicated a 1.47 relative risk (RR) for mortality.

Purpose of the Study:

  • To critically review the validity of existing cohort studies on hypopituitarism life expectancy.
  • To determine if study design flaws affect the calculated mortality risk.
  • To assess if the true relative risk is higher or lower than reported.

Main Methods:

  • Qualitative analysis of four published cohort studies.
  • Assessment of study design validity and potential biases.
  • Review of exclusion criteria and patient populations.

Related Experiment Videos

Main Results:

  • Cranial irradiation in one study may explain high cerebrovascular mortality.
  • A 40% increased risk for cardiac diseases remains unexplained by irradiation.
  • Validity issues in UK studies likely lead to under-estimation of the true RR.

Conclusions:

  • The observed 50% increased vascular mortality risk in hypopituitarism is likely an under-estimation.
  • Methodological limitations prevent precise quantification of the true relative risk.
  • Further research with improved study designs is needed to accurately assess mortality risk.